Hair cortisol concentrations in chronic central serous chorioretinopathy
- PMID: 31608607
- DOI: 10.1111/aos.14269
Hair cortisol concentrations in chronic central serous chorioretinopathy
Abstract
Purpose: Central serous chorioretinopathy (CSC), a distinct form of macular degeneration, has been associated with glucocorticoid use and possibly also with an increased endogenous activity of the hypothalamic-pituitary-adrenal (HPA) axis. To estimate long-term glucocorticoid exposure, measurement of hair cortisol concentrations (HCC) has emerged. This cross-sectional study aimed to investigate HCC, as a reflection of chronic endogenous steroid exposure, in a cohort of patients with chronic CSC (cCSC).
Methods: Hair cortisol concentrations (HCC) were determined in 48 patients with cCSC and 230 population-based controls (Lifelines cohort study), not using exogenous corticosteroids.
Results: Increased HCC (defined as >10.49 pg/mg) were present in 2 (4%) patients with cCSC and 13 (6%) controls. Mean HCC values were not different between patients and controls, and no difference in HCC was found between patients with active cCSC disease and patients with inactive disease. No correlation between HCC and urinary free cortisol (UFC) levels in patients with cCSC was found.
Conclusions: This study shows that HCC in patients with cCSC are not elevated compared to population-based controls, and no association between HCC and cCSC severity was found. This finding questions the previous suggestion that cCSC is associated with increased HPA axis activity. In line, HCC do not seem useful in monitoring cCSC disease activity.
Keywords: central serous chorioretinopathy; cortisol; hair cortisol; hypercortisolism; hypothalamic-pituitary-adrenal axis.
© 2019 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.
References
-
- Barnes PJ (2006): Corticosteroid effects on cell signalling. Eur Respir J 27: 413-426.
-
- Boyle B, Koranyi K, Patocs A, Liko I, Szappanos A, Bertalan R, Racz K & Balazs C (2008): Polymorphisms of the glucocorticoid receptor gene in Graves ophthalmopathy. Br J Ophthalmol 92: 131-134.
-
- Breukink MB, Dingemans AJ, den Hollander AI, et al. (2017): Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life. Clin Ophthalmol 11: 39-46.
-
- Caccavale A, Romanazzi F, Imparato M, Negri A, Morano A & Ferentini F (2011): Central serous chorioretinopathy: a pathogenetic model. Clin Ophthalmol 5: 239-243.
-
- Carvalho-Recchia CA, Yannuzzi LA, Negrao S, Spaide RF, Freund KB, Rodriguez-Coleman H, Lenharo M & Iida T (2002): Corticosteroids and central serous chorioretinopathy. Ophthalmology 109: 1834-1837.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
